Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24


Observations on the Inactivation Efficacy of a MALDI-TOF MS Chemical Extraction Method on Bacillus anthracis Vegetative Cells and Spores.

Weller SA, Stokes MG, Lukaszewski RA.

PLoS One. 2015 Dec 3;10(12):e0143870. doi: 10.1371/journal.pone.0143870. eCollection 2015.


Developing and understanding biofluid vibrational spectroscopy: a critical review.

Baker MJ, Hussain SR, Lovergne L, Untereiner V, Hughes C, Lukaszewski RA, Thiéfin G, Sockalingum GD.

Chem Soc Rev. 2016 Apr 7;45(7):1803-18. doi: 10.1039/c5cs00585j. Epub 2015 Nov 27. Review.


Polymerase Chain Reaction on a Viral Nanoparticle.

Carr-Smith J, Pacheco-Gómez R, Little HA, Hicks MR, Sandhu S, Steinke N, Smith DJ, Rodger A, Goodchild SA, Lukaszewski RA, Tucker JH, Dafforn TR.

ACS Synth Biol. 2015 Dec 18;4(12):1316-25. doi: 10.1021/acssynbio.5b00034. Epub 2015 Jul 1.


Control of intracellular Francisella tularensis by different cell types and the role of nitric oxide.

Newstead SL, Gates AJ, Hartley MG, Rowland CA, Williamson ED, Lukaszewski RA.

J Immunol Res. 2014;2014:694717. doi: 10.1155/2014/694717. Epub 2014 Jul 21.


CpG oligonucleotides protect against Venezuelan equine encephalitis virus infection in a route-dependent manner.

Rees DG, Phillpotts RJ, Griffin KF, Lukaszewski RA, Laws TR, Atkins HS, Krieg AM, Titball RW.

Int J Antimicrob Agents. 2013 Dec;42(6):587-8. doi: 10.1016/j.ijantimicag.2013.09.001. Epub 2013 Oct 1. No abstract available.


The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays.

Rees DG, Hartley MG, Green M, Lukaszewski RA, Griffin KF, Atkins HS, Lyons R, Krieg AM, Titball RW.

Microb Pathog. 2013 Oct;63:16-8. doi: 10.1016/j.micpath.2013.04.013. Epub 2013 May 22.


The use of colorimetric sensor arrays to discriminate between pathogenic bacteria.

Lonsdale CL, Taba B, Queralto N, Lukaszewski RA, Martino RA, Rhodes PA, Lim SH.

PLoS One. 2013 May 9;8(5):e62726. doi: 10.1371/journal.pone.0062726. Print 2013.


Targeting the "cytokine storm" for therapeutic benefit.

D'Elia RV, Harrison K, Oyston PC, Lukaszewski RA, Clark GC.

Clin Vaccine Immunol. 2013 Mar;20(3):319-27. doi: 10.1128/CVI.00636-12. Epub 2013 Jan 2. Review.


Evaluation of two multiplex real-time PCR screening capabilities for the detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis in blood samples generated from murine infection models.

Weller SA, Cox V, Essex-Lopresti A, Hartley MG, Parsons TM, Rachwal PA, Stapleton HL, Lukaszewski RA.

J Med Microbiol. 2012 Nov;61(Pt 11):1546-55. doi: 10.1099/jmm.0.049007-0. Epub 2012 Aug 16.


The potential of TaqMan Array Cards for detection of multiple biological agents by real-time PCR.

Rachwal PA, Rose HL, Cox V, Lukaszewski RA, Murch AL, Weller SA.

PLoS One. 2012;7(4):e35971. doi: 10.1371/journal.pone.0035971. Epub 2012 Apr 23.


Gene expression following low dose inhalational Francisella tularensis (SchuS4) exposure in Balb/c mice and the potential role of the epithelium and cell adhesion.

David J, Gates AJ, Griffiths GD, Lukaszewski RA.

Microbes Infect. 2012 Apr;14(4):369-79. doi: 10.1016/j.micinf.2011.11.006. Epub 2011 Nov 26.


Neutrophils are the predominant cell-type to associate with Burkholderia pseudomallei in a BALB/c mouse model of respiratory melioidosis.

Laws TR, Smither SJ, Lukaszewski RA, Atkins HS.

Microb Pathog. 2011 Dec;51(6):471-5. doi: 10.1016/j.micpath.2011.07.002. Epub 2011 Jul 20.


Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.

Easton A, Haque A, Chu K, Patel N, Lukaszewski RA, Krieg AM, Titball RW, Bancroft GJ.

J Infect Dis. 2011 Aug 15;204(4):636-44. doi: 10.1093/infdis/jir301.


Yersinia pseudotuberculosis is resistant to killing by human neutrophils.

Laws TR, Davey MS, Green C, Cooper IA, Titball RW, Lukaszewski RA.

Microbes Infect. 2011 Jun;13(6):607-11. doi: 10.1016/j.micinf.2011.02.004. Epub 2011 Feb 24.


Protective cellular responses to Burkholderia mallei infection.

Rowland CA, Lever MS, Griffin KF, Bancroft GJ, Lukaszewski RA.

Microbes Infect. 2010 Oct;12(11):846-53. doi: 10.1016/j.micinf.2010.05.012. Epub 2010 Jun 11.


Host immunity in the protective response to vaccination with heat-killed Burkholderia mallei.

Whitlock GC, Lukaszewski RA, Judy BM, Paessler S, Torres AG, Estes DM.

BMC Immunol. 2008 Sep 29;9:55. doi: 10.1186/1471-2172-9-55.


Presymptomatic prediction of sepsis in intensive care unit patients.

Lukaszewski RA, Yates AM, Jackson MC, Swingler K, Scherer JM, Simpson AJ, Sadler P, McQuillan P, Titball RW, Brooks TJ, Pearce MJ.

Clin Vaccine Immunol. 2008 Jul;15(7):1089-94. doi: 10.1128/CVI.00486-07. Epub 2008 May 14.


Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei.

Rowland CA, Lertmemongkolchai G, Bancroft A, Haque A, Lever MS, Griffin KF, Jackson MC, Nelson M, O'Garra A, Grencis R, Bancroft GJ, Lukaszewski RA.

Infect Immun. 2006 Sep;74(9):5333-40.


Administration of antibody to the lung protects mice against pneumonic plague.

Hill J, Eyles JE, Elvin SJ, Healey GD, Lukaszewski RA, Titball RW.

Infect Immun. 2006 May;74(5):3068-70.


Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils.

Lukaszewski RA, Kenny DJ, Taylor R, Rees DG, Hartley MG, Oyston PC.

Infect Immun. 2005 Nov;73(11):7142-50.


VP22 enhances antibody responses from DNA vaccines but not by intercellular spread.

Perkins SD, Hartley MG, Lukaszewski RA, Phillpotts RJ, Stevenson FK, Bennett AM.

Vaccine. 2005 Mar 14;23(16):1931-40.


CpG-DNA protects against a lethal orthopoxvirus infection in a murine model.

Rees DG, Gates AJ, Green M, Eastaugh L, Lukaszewski RA, Griffin KF, Krieg AM, Titball RW.

Antiviral Res. 2005 Feb;65(2):87-95.


Supplemental Content

Loading ...
Support Center